- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-TAF9
TAF9 Polyclonal Antibody for WB, IP, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, rat, souris
Applications
WB, IHC, IP, ELISA
Conjugaison
Non conjugué
N° de cat : 10544-1-AP
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | cellules HeLa, cellules HEK-293, cellules MCF-7, tissu cardiaque humain, tissu de côlon humain, tissu de muscle squelettique humain, tissu hépatique de rat |
| Résultats positifs en IP | tissu de muscle squelettique de souris |
Dilution recommandée
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| KD/KO | See 1 publications below |
| WB | See 6 publications below |
| IHC | See 2 publications below |
| IP | See 1 publications below |
Informations sur le produit
10544-1-AP cible TAF9 dans les applications de WB, IHC, IP, ELISA et montre une réactivité avec des échantillons Humain, rat, souris
| Réactivité | Humain, rat, souris |
| Réactivité citée | rat, Humain, souris |
| Hôte / Isotype | Lapin / IgG |
| Clonalité | Polyclonal |
| Type | Anticorps |
| Immunogène | TAF9 Protéine recombinante Ag0833 |
| Nom complet | TAF9 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 32kDa |
| Masse moléculaire calculée | 28 kDa |
| Poids moléculaire observé | 24-28 kDa |
| Numéro d’acquisition GenBank | BC007426 |
| Symbole du gène | TAF9 |
| Identification du gène (NCBI) | 6880 |
| Conjugaison | Non conjugué |
| Forme | Liquide |
| Méthode de purification | Purification par affinité contre l'antigène |
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
TAF9, also named as TAF2G, TAFII31, is a 264 amino acid protein, which belongs to the TAF9 family. TAF9 are involved in transcriptional activation as well as repression of distinct but overlapping sets of genes. TAF9 may have a role in gene regulation associated with apoptosis.
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for TAF9 antibody 10544-1-AP | Download protocol |
| IP protocol for TAF9 antibody 10544-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
| Species | Application | Title |
|---|---|---|
Cancers (Basel) Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models. | ||
Front Oncol Stable Isotope Tracing Uncovers Reduced γ/β-ATP Turnover and Metabolic Flux Through Mitochondrial-Linked Phosphotransfer Circuits in Aggressive Breast Cancer Cells. | ||
J Biol Chem The Cell Surface Hyaluronidase TMEM2 Regulates Cell Adhesion and Migration via Degradation of Hyaluronan at Focal Adhesion Sites. | ||
Front Pharmacol Activation of TAF9 via Danshensu-Induced Upregulation of HDAC1 Expression Alleviates Non-alcoholic Fatty Liver Disease.
| ||
J Proteome Res Targeted Proteomic Analysis Revealed Kinome Reprogramming during Acquisition of Radioresistance in Breast Cancer Cells. | ||
Mol Cell Proteomics Multi-Level Proteomics Reveals Epigenetic Signatures in BCG-mediated Macrophage Activation |
Avis
The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.
FH Aditya (Verified Customer) (10-08-2024) | good, very low on blot - convenient
|









